Dalarna University's logo and link to the university's website

du.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
The use and access to contraception in Sweden during the COVID-19 pandemic period.
Dalarna University, School of Health and Welfare, Sexual Reproductive Perinatal Health. Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm; Department of Women's and Children's Health, Karolinska Institutet, Stockholm.ORCID iD: 0000-0003-2813-7642
Department of Women's and Children's Health, Karolinska Institutet, Stockholm; WHO Collaborating Centre, Division of Gynecology and Reproduction, Karolinska University Hospital, Stockholm.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm; Department of Obstetrics and Gynecology, Danderyd Hospital, Stockholm.
2023 (English)In: European journal of contraception & reproductive health care, ISSN 1362-5187, E-ISSN 1473-0782, Vol. 28, no 5, p. 275-281Article in journal (Refereed) Published
Abstract [en]

PURPOSE: Explore perceived access to, the need for, use of, and satisfaction with telemedicine services for contraceptive counselling and prescription-renewal-only during the COVID-19 pandemic, and the impact of the COVID-19 pandemic period on the choice and use of contraceptives.

MATERIALS AND METHODS: Internet-based e-survey of Swedish women of fertile age, 16-49 years.

RESULTS: In total, 1016 participants completed the survey. Most participants (69.7%) rated their access to contraceptive services 'as usual'. Among the remaining participants, a higher proportion rated their access as deteriorated (73.4%) compared to improved (26.6%; p < 0.001). In total, 38.0% reported a need for contraceptive counselling, whereof 14.0% had used telemedicine for counselling and reported high satisfaction. Telemedicine for prescription-renewal-only was used by 15.1% of the total population. Two per cent reported use of another contraceptive than their intended, whereof long-acting reversible contraceptives were the most common intended method. The proportion of current contraceptive users was lower than in 2017 (62.4% vs 71.1%, p < 0.001), and current users of long-acting reversible contraception decreased from 30.6% to 19.3% (p < 0.001).

CONCLUSIONS: During the COVID-19 pandemic period, most women found their access to contraceptive services unaffected, but more women felt that it had deteriorated than improved. The use of telemedicine was low, and the use of contraception overall fell. Efforts are needed to raise awareness of available services, and TM-provided interventions for maintained quality of care and informed decision-making remain to be evaluated.

SHORT CONDENSATION The COVID-19 period imposed a change in contraceptive service provision, and efforts are needed to raise awareness of available services, including telemedicine. Access to all contraceptives, including LARCs, is crucial and telemedicine-provided interventions need evaluation.

Place, publisher, year, edition, pages
2023. Vol. 28, no 5, p. 275-281
Keywords [en]
Covid-19, SARS-CoV-2, access, contraception, contraceptives, telemedicine
National Category
Public Health, Global Health, Social Medicine and Epidemiology
Identifiers
URN: urn:nbn:se:du-47222DOI: 10.1080/13625187.2023.2260516ISI: 001099564300006PubMedID: 37902288Scopus ID: 2-s2.0-85175405738OAI: oai:DiVA.org:du-47222DiVA, id: diva2:1810048
Available from: 2023-11-06 Created: 2023-11-06 Last updated: 2023-12-28Bibliographically approved

Open Access in DiVA

fulltext(1103 kB)102 downloads
File information
File name FULLTEXT01.pdfFile size 1103 kBChecksum SHA-512
d1c70fbaca6d63ab86cd18ea7c23fd4d2e3bacfa3f00454f90936238234cebd42bf3aca44068f06559f6ea635510bea665d5e2da97269738784162a00541e2b0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Envall, Niklas

Search in DiVA

By author/editor
Envall, Niklas
By organisation
Sexual Reproductive Perinatal Health
In the same journal
European journal of contraception & reproductive health care
Public Health, Global Health, Social Medicine and Epidemiology

Search outside of DiVA

GoogleGoogle Scholar
Total: 108 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 166 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • chicago-author-date
  • chicago-note-bibliography
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf